Nadine MuskatelTungMD

Clinical Trials

• Fulvestrant With or Without Ganetespib in HR+ Breast Cancer Start of enrollment: 2012 May 01

  Active, not recruiting

  Phase 2

• Niraparib + Dostarlimab In BRCA Mutated Breast Cancer Start of enrollment: 2020 Dec 18

  Recruiting

  Phase 2

  Roles: Contact, Principal Investigator

• ATEMPT 2.0: Adjuvant T-DM1 vs TH Start of enrollment: 2021 Jun 16

  Recruiting

  Phase 2

• CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy Start of enrollment: 2020 Mar 13

  Recruiting

  Phase 2

• Atezolizumab + Sacituzumab Govitecan to Prevent Recurrence in TNBC (ASPRIA) Start of enrollment: 2020 Jul 02

  Active, not recruiting

  Phase 2

  Roles: Contact, Principal Investigator

• A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast Cancer Start of enrollment: 2021 Jan 11

  Recruiting

  Phase 2

  Roles: Principal Investigator, Contact

• The AVIATOR Study: Trastuzumab and Vinorelbine With Avelumab OR Avelumab & Utomilumab in Advanced HER2+ Breast Cancer Start of enrollment: 2018 Jun 21

  Active, not recruiting

  Phase 2

  Roles: Principal Investigator, Contact

• Olaparib In Metastatic Breast Cancer Start of enrollment: 2018 Apr 01

  Active, not recruiting

  Phase 2

  Roles: Contact, Principal Investigator

• Join now to see all